ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 64 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,212,105 | -65.8% | 337,052 | -60.6% | 0.00% | -66.7% |
| Q1 2023 | $9,402,074 | -21.9% | 854,734 | +5.1% | 0.00% | -25.0% |
| Q4 2022 | $12,042,000 | -3.7% | 813,622 | +24.3% | 0.00% | -20.0% |
| Q3 2022 | $12,510,000 | +7.9% | 654,678 | +20.3% | 0.01% | +25.0% |
| Q2 2022 | $11,596,000 | +40.0% | 544,188 | +26.5% | 0.00% | +100.0% |
| Q1 2022 | $8,285,000 | +84.6% | 430,262 | +98.8% | 0.00% | +100.0% |
| Q4 2021 | $4,489,000 | -48.1% | 216,403 | -40.2% | 0.00% | -66.7% |
| Q3 2021 | $8,655,000 | -10.6% | 362,035 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $9,686,000 | +5.6% | 354,880 | +11.9% | 0.00% | 0.0% |
| Q1 2021 | $9,176,000 | +183.4% | 317,203 | +175.5% | 0.00% | +200.0% |
| Q4 2020 | $3,238,000 | -61.1% | 115,117 | -59.5% | 0.00% | -66.7% |
| Q3 2020 | $8,334,000 | -0.9% | 284,446 | +2.3% | 0.00% | -25.0% |
| Q2 2020 | $8,407,000 | +10.9% | 278,019 | +9.3% | 0.00% | 0.0% |
| Q1 2020 | $7,584,000 | – | 254,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $165,956,000 | 12.78% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $57,330,000 | 6.84% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,874,000 | 3.97% |
| Logos Global Management LP | 1,525,000 | $29,143,000 | 3.58% |
| 1492 Capital Management LLC | 178,320 | $3,408,000 | 2.45% |
| Cormorant Asset Management, LP | 1,000,000 | $19,110,000 | 1.34% |
| MPM BioImpact LLC | 257,185 | $4,915,000 | 1.16% |
| Orbimed Advisors | 2,800,000 | $53,508,000 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 220,985 | $4,223,000 | 0.83% |
| Rubric Capital Management LP | 472,047 | $9,021,000 | 0.45% |